Five companies
One group
Firalis Group provides integrated, end-to-end solutions delivered by our specialised teams in Huningue, France — from biomarker discovery through to CE-IVDR and FDA clearance, IVD CDMO services and commercialisation.
The groupFive companies
The group
- 5Companies
- 8Services
- 2008Founded
Quality management system
CertificationAFNOR / AFAQNo. 2014/58992.7
Development and production of immunoassays
CertificationAFNOR / AFAQNo. 2014/58993.6
Environmental management
CertificationAFNOR / AFAQ
Testing activities
AccreditationCOFRACNo. 8-3139
Biobanking for research
CertificationAFNOR / AFAQNo. 2024/108791.1
Information security management
Certification
In vitro diagnostic quality management system
Certification
Held by Firalis SAS. A certificate names a single legal entity — it is not group-wide.
Firalis Group brings close to 20 years of experience in the biomarker space and has played a pivotal role in supporting innovation at every stage.
The continuum
One chain, four stages, full support.
Each stage stands on its own. Engage one stage, or let us manage the entire journey — from Discovery to Commercialisation.
What we offer
One integrated chain of services
Each service is delivered by the Firalis Group company best equipped to lead it, with a seamless connection across the Group.
- BioproductionAsk Firalis to produce your critical compounds.Firalis
- Biobanking & clinical samplesISO 20387 certified biobanking, qualified clinical sample supply and long-term storage.Firalis
- Clinical & translational researchConsortium coordination and GCLP-compliant biomarker analysis, from protocol to qualification.Firalis
- Biomarker discoveryDiscovery, development and regulatory qualification of biomarkers for cardiovascular disease.Firalis
- Neurological pipelineDiscovery, development and regulatory qualification of biomarkers for neurological disease.Amoneta
- IVD & assay developmentContract development and manufacturing for RUO and in vitro diagnostics assays.IVDias
- Digital pathologyIntelligent, quantitative image analysis for histopathology.BioCellvia
- Micropollutant analysisDetection and quantification of micropollutants in complex matrices.Lodiag
News
Latest from the group
-
Firalis has sold its majority stake in Firalis Molecular Precision to Janvier Group Biosciences, and the business now operates as Precursion.
-
A fourth consecutive year at the International Conference on Alzheimer’s and Parkinson’s Diseases. The APOE work is what the team brings to it.
-
The group’s APOE genotyping test clears Regulation (EU) 2017/746 — the framework that replaced the IVD Directive and raised the bar for every European test.
Talk to the group
A programme, a partnership, or a question about where to start.